Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Evalve Inc.

Division of Abbott Laboratories Inc.
www.evalveinc.com

Latest From Evalve Inc.

Functional MR Added To FDA-Approved Indication For Abbott's MitraClip

The new indication covers functional mitral regurgitation, also known as secondary mitral regurgitation, which represents two-to-three times as many patients as the primary mitral regurgitation population MitraClip is already labeled for. The approval is supported by results from the COAPT trial, the first randomized trial to show that a mitral-valve repair could improve outcomes in patients with secondary mitral regurgitation.

Approvals Commercial

Abbott Advances Transcath Mitral Valve Efforts With Cephea Acquisition

Abbott has exercised an option to buy Cephea Valve Technologies, developer of a minimally-invasive replacement heart valve, for an undisclosed sum.

Cardiovascular M & A

Medical Device Start-Up News, August 2012

This month we profile CoolSpine and its catheter-based hypothermia device, Inseal Medical and its large-bore vascular closure device, and MitrAssist Medical, which is developing a valve-in-valve approach to treating mitral regurgitation.

Medical Device

MitrAssist Medical Ltd.

Just as people improve their vision by wearing glasses or contact lenses instead of repairing or replacing their eyes, a mitral valve prosthesis from Israeli-based MitrAssist Medical Ltd. neither repairs nor replaces damaged mitral valves in the heart, but rather it augments and enhances native valve function. The company’s implant is placed on top of the native valve and anchored securely. This “valve-in-valve” approach is designed to prevent leakage and restore normal blood flow.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • Ferolyn Powell, Pres. & CEO
    Doug Hughes, CFO
    Troy Thornton, VP, R&D
    Sean Cleary, SVP, Worldwide Sales & Mktg.
  • Contact Info
  • Evalve Inc.
    Phone: (650) 330-8100
    4045 Campbell Ave.
    Menlo Park, CA 94025
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register